GASTRIC ADENOCARCINOMA

This large Phase 3 trial tested whether adding a new immune-boosting drug called AK104 to standard chemotherapy works better than chemotherapy alone for people with advanced stomach or gastroesophageal cancer. The study involved 610 adults who had not received prior treatment for…

This study tested whether combining two drugs, TAS-102 and ramucirumab, is safe and can help people with advanced stomach or gastroesophageal cancer that has stopped responding to other treatments. It involved 23 patients to see if the combination could help them live longer and …

This study tested the safety and how the body processes an experimental drug called SGN-B6A in Chinese patients with advanced solid tumors. It involved a small group of 6 participants who had cancers like lung, head and neck, or stomach cancer that had stopped responding to stand…

This early-stage study aimed to find a safe and effective dose of a new drug called TPST-1495, given alone or with an existing immunotherapy (pembrolizumab), for people with advanced solid tumors. It enrolled 89 adults with cancers like colorectal, lung, and head and neck cancer …

This study looked back at medical records to compare two types of stomach cancer surgery. Researchers examined 96 patients who had either partial removal (proximal gastrectomy) or full removal (total gastrectomy) of their stomach. They wanted to see which approach led to better s…

This study aimed to understand why people with stomach or esophageal cancer sometimes wait to see a doctor after their first symptoms appear. Researchers surveyed 258 patients in France to learn if personal feelings, thoughts, or social factors influenced this delay. The goal is …